Immediate PRN Management for Blood Glucose of 417 mg/dL
Administer a corrective dose of rapid-acting insulin (such as regular insulin or rapid-acting analog) according to your institution's correction factor scale, typically 2-6 units subcutaneously depending on the patient's insulin sensitivity, and reassess the overall insulin regimen immediately as SSI alone is inadequate for this level of hyperglycemia. 1
Why SSI Alone is Failing
Sliding scale insulin (SSI) is condemned in clinical guidelines and is associated with clinically significant hyperglycemia in many patients. 1 A glucose of 417 mg/dL in a patient already on SSI and NPH demonstrates that the current regimen is insufficient.
The evidence consistently shows that SSI used alone is a reactive therapy that does not maintain adequate glycemic control in hospitalized patients. 1, 2
Immediate PRN Correction
For the acute glucose of 417 mg/dL:
Give corrective rapid-acting insulin subcutaneously based on your correction factor scale (typically part of your SSI protocol). 1
Recheck blood glucose in 2-4 hours to assess response and determine if additional correction is needed. 1
Most SSI protocols use regular insulin or rapid-acting analogs for correction doses, with the dose determined by how far above target the glucose is (commonly 1-2 units per 50 mg/dL above 150 mg/dL, though this varies by patient sensitivity). 1
Critical Next Step: Transition to Basal-Bolus Regimen
This patient requires immediate transition from SSI alone to a proper basal-bolus insulin regimen, as randomized trials consistently show better glycemic control and reduced complications with basal-bolus compared to SSI alone. 1
Recommended Approach:
Calculate total daily insulin dose (TDD) at 0.3-0.5 units/kg body weight for insulin-naive or low-dose patients. 1
Allocate 50% of TDD to basal insulin (NPH given twice daily or long-acting analog once daily) and 50% to rapid-acting insulin divided before three meals. 1
Add correction factor dosing (rapid-acting insulin) before meals and at bedtime for glucose elevations. 1
For patients already on higher insulin doses at home (≥0.6 units/kg/day), reduce the TDD by 20% during hospitalization to prevent hypoglycemia. 1
Important Caveats
Lower initial doses (0.3 units/kg) should be used for patients at higher risk of hypoglycemia: those over 65 years old, patients with renal failure, and those with poor oral intake. 1
The basal-bolus approach carries 4-6 times higher risk of hypoglycemia than SSI (risk ratio 5.75 for glucose ≤70 mg/dL), so close monitoring is essential. 1
For patients who are NPO or have poor oral intake, consider a basal-plus approach (basal insulin 0.1-0.25 units/kg/day plus correction doses every 6 hours) rather than full basal-bolus. 1
Monitoring Requirements
Check blood glucose every 2-4 hours initially until stable, then before meals and at bedtime. 1
Target glucose range of 140-180 mg/dL is appropriate for most hospitalized patients (less stringent than the 417 mg/dL currently observed). 1
Adjust insulin doses daily based on patterns of hyperglycemia or hypoglycemia. 1